Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
10/29/2003EP1355891A2 Therapy
10/29/2003EP1355684A1 Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy
10/29/2003EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
10/29/2003EP1108212B1 Methods and materials for diagnosing unstable angina
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP0920501B1 Neuritin, a neurogene
10/29/2003EP0763105B1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
10/29/2003EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003EP0602193B1 Enhanced expression in plants
10/29/2003EP0293394B2 Novel thrombolytic proteins
10/29/2003CN1452661A Viral vectors for use in monitoring HIV drug resistance
10/29/2003CN1452660A Methods for stable transformation of plants
10/29/2003CN1452658A Process for production of human interferon alpha from genetically engineered yeast
10/29/2003CN1452655A Method of culturing mesenchymal stem cells
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452635A Recombinant fusion protein for diagnosis of tsutsugamushi disease
10/29/2003CN1452633A Mammalian genes, related reagent and methods
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452493A Method for cell adhesion and wound healing
10/29/2003CN1452473A Container assembly for fertilization and culture and embryo transfer and method for fertilization and culture employing such container
10/29/2003CN1451754A Rice flavamonocell hrf 1 gene recombinant vector and transgene plant breeding method
10/29/2003CN1451750A Rice flavamonocell hrf3 gene, recombinant vector and breeding method for plant transgene
10/29/2003CN1451743A Method for alleviating scar healing-up by external research
10/29/2003CN1451664A Rice flavamonocell hrf2 gene, recombinant vector and method for transgenic breeding plant therefor
10/29/2003CN1125878C Method for creating transgenic receptor system of corn and application of same
10/28/2003US6639128 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
10/28/2003US6639127 Isolated and purified hop lupulin gland-specific promoter
10/28/2003US6639125 Dull1 coding for a starch synthase and uses thereof
10/28/2003US6639123 Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight
10/28/2003US6639121 Transgenic mouse comprising an oncogene operably linked to a promoter that can be regulated by reverse tetracycline transactivator and doxycycline; repeatedly inducible, reducible and re-inducible by controlling transactivator
10/28/2003US6639065 Development of an artificial DNA sequence on the basis of computational analysis of various genes which express at high level in plants
10/28/2003US6639063 Signal peptide directs the secretion of a polypeptide when located at the amino terminus of a polypeptide
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6639050 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638768 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638765 Platform for the differentiation of cells
10/28/2003US6638763 Neurons and glia arise from stem/precursor cells of these cultures; culturing under conditions that inhibit cell-cell and cell-substrate interactions results in a substantially homogeneous population of pluripotent brain stem cells
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638751 Isolated human zinc protease proteins
10/28/2003US6638747 Isolated polypeptide having specified amino acid sequence
10/28/2003US6638741 Differentiation-suppressive polypeptide serrate-2
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638731 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment of alzheimer's disease
10/28/2003US6638710 Adsorbent for reducing the concentration of fibrinogen and/or fibrin, method of producing an adsorber from the adsorbent, and an adsorber with the adsorbent
10/28/2003US6638709 Processes for making cryopreserved composite living constructs and products resulting therefrom
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638501 Use of multipotent neural stem cell progeny to augment non-neural tissues
10/28/2003US6637437 Cell-culture and polymer constructs
10/26/2003CA2425886A1 Root-specific conifer gene promoter and its use
10/23/2003WO2003087836A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003WO2003087399A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
10/23/2003WO2003087392A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087376A1 Caffeine synthase and use thereof
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003WO2003087365A1 Method of measuring human cyp3a inducibility
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087350A1 Control of cell differentiation through formation of three-dimensional aggregate
10/23/2003WO2003087349A1 METHOD OF FORMING PANCREATIC β CELLS FROM MESENCHYMAL CELLS
10/23/2003WO2003087348A1 Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
10/23/2003WO2003087347A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003WO2003087346A1 Embryo modification and implantation
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087341A2 Targeted chromosomal mutagenesis using zinc finger nucleases
10/23/2003WO2003087340A2 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087337A2 Vascularized human skin equivalent
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087314A2 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087305A2 Methods and compositions for anchoring stem cells in a microenvironment
10/23/2003WO2003087303A2 Tissue composites and uses thereof
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003087292A2 Automated tissue engineering system
10/23/2003WO2003087160A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087115A2 Oligomeric compounds having modified phosphate groups
10/23/2003WO2003086456A2 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer